Loading data for OZEM — first visit, this takes a few seconds.

Roundhill Glp-1 & Weight Loss ETF (OZEM)

NasdaqGM: OZEM · 即時價格 · USD

31.13

-2.47 (-7.35%)

收盤價： Sep 11, 2026, 8:00 PM

31.10

-0.11%

盤後: 7:30 PM

提醒

Alert

買價	23.33
市值	不適用
AUM	63.57M
資產淨值	31.66
貝他值	0
EPS (ttm)	不適用
本益比（ttm）	16.82
分享出去	不適用
成立日期	May 20, 2024

賣價	41.71
成交量	18,357
20 日平均成交量	21,742
開盤價	33.52
前收盤價	33.60
當日區間	33.22 - 33.52
52 週範圍	25.66 - 37.15
持股	不適用
總費用率	0.59%

關於 OZEM

The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified.

資產類別 Equity

股票代號 OZEM

成立日期 May 20, 2024

提供者 Roundhill Investments

網站基金首頁

交流 NasdaqGM

類股	重量%
Healthcare	100%

十大持股 52.95 資產%

名稱	代號	重量
Eli Lilly And Co	LLY	12.02%
Pfizer Inc	PFE	7.42%
Cspc Pharmaceutical ...	1093.HK	6.91%
Viking Therapeutics ...	VKTX	4.84%
Hanmi Pharm Co Ltd	128940.KQ	4.82%
Amgen Inc	AMGN	4.49%
Kailera Therapeutics...	KLRA	4.27%
Chugai Pharmaceutica...	4519.T	4.12%
Zealand Pharma As	ZEAL.CO	4.06%

查看更多持股

股利股利殖利率 1.32%

前股利	金額	付款日期
Dec 30, 2025	$0.4100	不適用
Dec 30, 2024	$0.0530	不適用

股利完整歷史記錄

價格為何變動

新聞動態

2 月前 · Zacks

Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage

Medicare's new GLP-1 coverage could expand access to weight-loss drugs, making ETFs a diversified way to tap growth across the obesity treatment market.

2 月前 · MarketBeat

3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend

With GLP-1 usage continuing to rise, a group of unlikely beneficiaries is emerging; stocks in the broader health care sector and even in retail could stand out.